Cifurtilimab

Tax included
Cifurtilimab (SEA-CD40) is an agonistic nonfucosylated, humanized IgG1 monoclonal antibody directed against CD40. Cifurtilimab shows antitumor activities.
HY-P99603

Data sheet

Size
Multiple sizes
Reactivity
Others
CAS
1629760-27-5